Search Results - "Morse, Caryn"

Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19: A Randomized Clinical Trial by Clemency, Brian M, Varughese, Renoj, Gonzalez-Rojas, Yaneicy, Morse, Caryn G, Phipatanakul, Wanda, Koster, David J, Blaiss, Michael S

“…Systemic corticosteroids are commonly used in treating severe COVID-19. However, the role of inhaled corticosteroids in the treatment of patients with mild to…”
Get more information

Fatty liver disease in HIV: common, underappreciated, and understudied by Morse, Caryn G

Get full text

S1869 Delayed Gastric Emptying Among Persons Living With HIV: A Control-Matched Retrospective Cohort Study by Maffei, Vincent J., Morse, Caryn G., Weinberg, Richard B.

Get full text

Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial by Meissner, Eric G., McLaughlin, Mary, Matthews, Lindsay, Gharib, Ahmed M., Wood, Bradford J., Levy, Elliot, Sinkus, Ralph, Virtaneva, Kimmo, Sturdevant, Dan, Martens, Craig, Porcella, Stephen F., Goodman, Zachary D., Kanwar, Bittoo, Myers, Robert P., Subramanian, Mani, Hadigan, Colleen, Masur, Henry, Kleiner, David E., Heller, Theo, Kottilil, Shyam, Kovacs, Joseph A., Morse, Caryn G.

“…Background Chronic liver injury can result in fibrosis that may progress over years to end‐stage liver disease. The most effective anti‐fibrotic therapy is…”
Get full text

Increased Body Mass Index and Type 2 Diabetes Are the Main Predictors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Liver Biopsies of Patients With Human Immunodeficiency Virus Monoinfection by Maurice, James B, Goldin, Robert, Hall, Andrew, Price, Jennifer C, Sebastiani, Giada, Morse, Caryn G, Prat, Laura Iogna, Perazzo, Hugo, Garvey, Lucy, Ingiliz, Patrick, Guaraldi, Giovanni, Tsochatzis, Emmanouil, Lemoine, Maud

“…Liver disease is an important cause of morbidity and mortality in people living with human immunodeficiency virus (PLWH), of which nonalcoholic fatty liver…”
Get full text

New Drugs for NASH and HIV Infection: Great Expectations for a Great Need by Guaraldi, Giovanni, Maurice, James B., Marzolini, Catia, Monteith, Kenneth, Milic, Jovana, Tsochatzis, Emmanuel, Bhagani, Sanjay, Morse, Caryn G., Price, Jennifer C., Ingiliz, Patrick, Lemoine, Maud, Sebastiani, Giada

“…In recent years, there has been an increasing number of clinical trials for the treatment of nonalcoholic steatohepatitis (NASH). People living with human…”
Get full text

Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1–Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy by Morse, Caryn G., McLaughlin, Mary, Matthews, Lindsay, Proschan, Michael, Thomas, Francine, Gharib, Ahmed M., Abu-Asab, Mones, Orenstein, Abigail, Engle, Ronald E., Hu, Xiaojun, Lempicki, Richard, Hadigan, Colleen, Kleiner, David E., Heller, Theo, Kovacs, Joseph A.

“…Background. Persistent aminotransferase elevations are common in human immunodeficiency virus (HIV)–infected patients on antiretroviral therapy (ART),…”
Get full text

Transient elastography for the detection of hepatic fibrosis in HIV-monoinfected adults with elevated aminotransferases on antiretroviral therapy by Morse, Caryn G, McLaughlin, Mary, Proschan, Michael, Koh, Christopher, Kleiner, David E, Heller, Theo, Kovacs, Joseph A

“…Vibration-controlled transient elastography (VCTE) is increasingly used to assess liver fibrosis in viral hepatitis and fatty liver disease populations…”
Get full text

Letter to the Editor: People living with HIV and NAFLD-A population left behind in the global effort for liver fibrosis screening? by Sebastiani, Giada, Milic, Jovana, Tsochatzis, Emmanuel A, Marzolini, Catia, Betel, Michael, Bhagani, Sanjay, Morse, Caryn G, Cinque, Felice, Maurice, James B, Ingiliz, Patrick, Price, Jennifer, Lemoine, Maud, Rockstroh, Jürgen K, Guaraldi, Giovanni

Get full text

Exploring the consequences of food insecurity and harnessing the power of peer navigation and mHealth to reduce food insecurity and cardiometabolic comorbidities among persons with HIV: protocol for development and implementation trial of weCare/Secure by Tanner, Amanda E, Palakshappa, Deepak, Morse, Caryn G, Mann-Jackson, Lilli, Alonzo, Jorge, Garcia, Manuel, Wright, Elena, Dharod, Ajay, Isom, Scott, Sucaldito, Ana D, Aviles, Lucero Refugio, Rhodes, Scott D

“…Food insecurity, or the lack of consistent access to nutritionally adequate and safe foods, effects up to 50% of people living with HIV (PWH) in the…”
Get full text

Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease by Abd-Elmoniem, Khaled Z., Sinkus, Ralph, Levy, Elliot, Myers, Robert P., Subramanian, G. Mani, Kottilil, Shyam, Heller, Theo, Kovacs, Joseph A., Morse, Caryn G., Rizvi, Bisharah, Matthews, Lindsay, McLaughlin, Mary, Zhao, Xiongce, Kleiner, David E., Meissner, Eric G., Han, Ma Ai Thanda, Gharib, Ahmed M., Koh, Christopher

“…Background. Portal hypertension, an elevation in the hepatic venous pressure gradient (HVPG), can be used to monitor disease progression and response to…”
Get full text

Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates by Mollan, Katie R, Eron, Joseph J, Krajewski, Taylor J, Painter, Wendy, Duke, Elizabeth R, Morse, Caryn G, Goecker, Erin A, Premkumar, Lakshmanane, Wolfe, Cameron R, Szewczyk, Laura J, Alabanza, Paul L, Loftis, Amy James, Degli-Angeli, Emily J, Brown, Ariane J, Dragavon, Joan A, Won, John J, Keys, Jessica, Hudgens, Michael G, Fang, Lei, Wohl, David A, Cohen, Myron S, Baric, Ralph S, Coombs, Robert W, Sheahan, Timothy P, Fischer, William A

“…Abstract Background Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectious virus isolation in outpatients with coronavirus disease…”
Get full text

Prevalence and Correlates of Electrocardiographic Abnormalities in Adults With HIV: Insights From the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) by Bloomfield, Gerald S., Weir, Isabelle R., Ribaudo, Heather J., Fitch, Kathleen V., Fichtenbaum, Carl J., Moran, Laura E., Bedimo, Roger, de Filippi, Christopher, Morse, Caryn G., Piccini, Jonathan, Zanni, Markella V., Lu, Michael T., Hoffmann, Udo, Grinspoon, Steven K., Douglas, Pamela S.

“…People with HIV (PWH) are at increased risk of cardiovasvular disease (CVD) and sudden cardiac death. Previous work has suggested an association between HIV…”
Get full text

Metabolic and Skeletal Complications of HIV Infection: The Price of Success by Morse, Caryn G, Kovacs, Joseph A

“…Over the past 10 years, in conjunction with the broad availability of potent antiretroviral regimens, the care of human immunodeficiency virus (HIV)–infected…”
Get full text

Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease by Nelson, Adam J, O'Brien, Emily C, Kaltenbach, Lisa A, Green, Jennifer B, Lopes, Renato D, Morse, Caryn G, Al-Khalidi, Hussein R, Aroda, Vanita R, Cavender, Matthew A, Gaynor, Tanya, Kirk, Julienne K, Lingvay, Ildiko, Magwire, Melissa L, McGuire, Darren K, Pak, Jonathan, Pop-Busui, Rodica, Richardson, Caroline R, Senyucel, Cagri, Kelsey, Michelle D, Pagidipati, Neha J, Granger, Christopher B

“…Based on contemporary estimates in the US, evidence-based therapies for cardiovascular risk reduction are generally underused among patients with type 2…”
Get full text

Ultrarapid Measurement of Diagnostic Antibodies by Magnetic Capture of Immune Complexes by Burbelo, Peter D., Gunti, Sreenivasulu, Keller, Jason M., Morse, Caryn G., Deeks, Steven G., Lionakis, Michail S., Kapoor, Amit, Li, Qingxue, Cohen, Jeffrey I., Notkins, Abner L., Alevizos, Ilias

“…Rapid point-of-care, antibody-based testing is not currently available for the diagnosis of most autoimmune and infectious diseases. Here we report a simple,…”
Get full text

Cardiology Encounters for Underrepresented Racial and Ethnic Groups with Human Immunodeficiency Virus and Borderline Cardiovascular Disease Risk by Bloomfield, Gerald S., Hill, C. Larry, Chiswell, Karen, Cooper, Linda, Gray, Shamea, Longenecker, Chris T., Louzao, Darcy, Marsolo, Keith, Meissner, Eric G., Morse, Caryn G., Muiruri, Charles, Thomas, Kevin L., Velazquez, Eric J., Vicini, Joseph, Pettit, April C., Sanders, Gretchen, Okeke, Nwora Lance

“…Background Underrepresented racial and ethnic groups (UREGs) with HIV have a higher risk of cardiovascular disease (CVD) compared with the general population…”
Get full text

Altered antibody profiles against common infectious agents in chronic disease by Burbelo, Peter D, Ching, Kathryn H, Morse, Caryn G, Alevizos, Ilias, Bayat, Ahmad, Cohen, Jeffrey I, Ali, Mir A, Kapoor, Amit, Browne, Sarah K, Holland, Steven M, Kovacs, Joseph A, Iadarola, Michael J

“…Despite the important diagnostic value of evaluating antibody responses to individual human pathogens, antibody profiles against multiple infectious agents…”
Get full text

Unanticipated increases in hepatic steatosis among human immunodeficiency virus patients receiving mineralocorticoid receptor antagonist eplerenone for non‐alcoholic fatty liver disease by Chaudhury, Chloe S., Purdy, Julia B., Liu, Chia‐Ying, Morse, Caryn G., Stanley, Takara L., Kleiner, David, Hadigan, Colleen

“…Background & Aims Non‐alcoholic fatty liver disease is common in human immunodeficiency virus, but there are no approved therapies. The aim of this open‐label…”
Get full text

Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial by Kumar, Princy N, Hernández-Sánchez, Jules, Nagel, Sandra, Feng, Yuning, Cai, Fang, Rabin, Joseph, Morse, Caryn G, Nadig, Nandita R, Ashraf, Obaid, Gotur, Deepa B, McComsey, Grace A, Gafoor, Khalid, Perin, Patrick, Thornton, Sarah C, Stubbings, William, Lin, Celia J F, Tsai, Larry

“…Abstract Background Tocilizumab, an interleukin 6 receptor (IL-6R) antagonist monoclonal antibody, has shown efficacy in patients with coronavirus disease 2019…”
Get full text